Low-dose emapalumab treatment in refractory macrophage activation syndrome secondary to adult onset still's disease/systemic lupus erythematosus: insights from nine cases. [PDF]
Chen J +9 more
europepmc +1 more source
Turmeric and <i>Eucalyptus</i> Aqueous Extracts Reduced Inflammation in Macrophage Activation Syndrome (MAS) Mouse Model. [PDF]
Al-Omari MM +3 more
europepmc +1 more source
Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg
Courtney Crayne, Randy Q. Cron
doaj
T-ing up the storm: pathogenic cycling lymphocytes in the biology of macrophage activation syndrome. [PDF]
Lam MT, Jiang CL, Lee PY.
europepmc +1 more source
Etiologies and long-term outcome of pediatric hemophagocytic lymphohistiocytosis and macrophage activation syndrome in Taiwan: a single-center retrospective study. [PDF]
Wang CY +9 more
europepmc +1 more source
Effective Treatment of Macrophage Activation Syndrome Linked to Systemic Lupus Erythematosus Using Interleukin-1 Inhibitor. [PDF]
Barlas N +4 more
europepmc +1 more source
Intravenous Anakinra for Treating Macrophage Activation Syndrome in Adult-Onset Still's Disease. [PDF]
Bitik B +6 more
europepmc +1 more source
Management Challenge of Coexistence of Macrophage Activation Syndrome, Systemic Lupus Erythematosus, and Hepatitis B: Case Report. [PDF]
Rakotonirina LN +5 more
europepmc +1 more source

